Andreea Elena Miron (Lungu)
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andreea Elena Miron (Lungu) has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Cristina Prejmerean
Department of Polymer Composites, Raluca Ripan Institute for Research in Chemistry, Babeș-Bolyai University, 30 Fântânele Str., 400294 Cluj-Napoca, Romania
1 shared publication - Doina Prodan
Raluca Ripan Institute for Research in Chemistry, Babeş-Bolyai University, 30 Fântânele Street, 400294 Cluj-Napoca, Romania
1 shared publication - Marioara Moldovan
Department of Polymer Composites, Raluca Ripan Institute for Research in Chemistry, Babeş-Bolyai University, 30 Fântânele Street, 400294 Cluj-Napoca, Romania
1 shared publication - Mihaela Vlassa
Raluca Ripan Institute for Research in Chemistry, Babeș-Bolyai University, 400294 Cluj-Napoca, Romania
1 shared publication - Mindra Eugenia Badea
Faculty of Dentistry, Iuliu Hațieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania
1 shared publication - Miuța Filip
Raluca Ripan Institute for Research in Chemistry, Babeş-Bolyai University, 30 Fântânele Street, 400294 Cluj-Napoca, Romania
1 shared publication
Latest Publications
- Open Access
New Antimicrobial Biomaterials for the Reconstruction of Craniofacial Bone Defects
Reconstructive bone surgery of the head and neck could prove challenging in terms of postoperative healing and recovery. Fighting infection during the healing period is one of the critical factors of the long-term survival of an implant. The aim of the study was to develop an innovative composition suitable for an antibacterial craniofacial implant that should have the capacity to continuously and constantly release the amount of gentamicin necessary to prevent the post-surgical infections. For this purpose, a series of composite materials based on dimethacrylic monomers, hydroxyapatite and ZrO2, with (series B) or without the addition of polymethyl methacrylate (series A), reinforced with woven E-glass fibers (FRC) were obtained using the laminate lay-up process. Gentamicin was included in all FRC sample matrices to confer an antimicrobial effect. The results show that after extraction of the residual monomers from the FRC samples in different solvents (chloroform, acetone and ethyl alcohol), the cumulative amount of released gentamicin after 12 days was between 7.05–11.38 mg for A samples and 11.21–14.52 mg for B samples. The microbiological protocol showed that gentamicin induces a two weeks-lasting antimicrobial effect maintained over the minimal inhibitory concentration for P. aeruginosa and S. aureus.
Open AccessNew Antimicrobial Biomaterials for the Reconstruction of Craniofacial Bone Defects
Reconstructive bone surgery of the head and neck could prove challenging in terms of postoperative healing and recovery. Fighting infection during the healing period is one of the critical factors of the long-term survival of an implant. The aim of the study was to develop an innovative composition suitable for an antibacterial craniofacial implant that should have the capacity to continuously and constantly release the amount of gentamicin necessary to prevent the post-surgical infections. For this purpose, a series of composite materials based on dimethacrylic monomers, hydroxyapatite and ZrO2, with (series B) or without the addition of polymethyl methacrylate (series A), reinforced with woven E-glass fibers (FRC) were obtained using the laminate lay-up process. Gentamicin was included in all FRC sample matrices to confer an antimicrobial effect. The results show that after extraction of the residual monomers from the FRC samples in different solvents (chloroform, acetone and ethyl alcohol), the cumulative amount of released gentamicin after 12 days was between 7.05–11.38 mg for A samples and 11.21–14.52 mg for B samples. The microbiological protocol showed that gentamicin induces a two weeks-lasting antimicrobial effect maintained over the minimal inhibitory concentration for P. aeruginosa and S. aureus.